136 related articles for article (PubMed ID: 11887801)
21. Isolation, characterization and crystallization of a phospholipase A2 myotoxin from the venom of the prairie rattlesnake (Crotalus viridis viridis).
Ownby CL; Colberg TR; White SP
Toxicon; 1997 Jan; 35(1):111-24. PubMed ID: 9028014
[TBL] [Abstract][Full Text] [Related]
22. Biological versatility of crotamine--a cationic peptide from the venom of a South American rattlesnake.
Kerkis I; Silva Fde S; Pereira A; Kerkis A; Rádis-Baptista G
Expert Opin Investig Drugs; 2010 Dec; 19(12):1515-25. PubMed ID: 21062230
[TBL] [Abstract][Full Text] [Related]
23. Cloning and nucleotide sequences of crotamine genes.
Smith LA; Schmidt JJ
Toxicon; 1990; 28(5):575-85. PubMed ID: 2389256
[TBL] [Abstract][Full Text] [Related]
24. Origins, genomic structure and copy number variation of snake venom myotoxins.
Gopalan SS; Perry BW; Schield DR; Smith CF; Mackessy SP; Castoe TA
Toxicon; 2022 Sep; 216():92-106. PubMed ID: 35820472
[TBL] [Abstract][Full Text] [Related]
25. Membrane-modifying properties of crotamine, a small peptide-toxin from Crotalus durissus terifficus venom.
Sieber M; Bosch B; Hanke W; Fernandes de Lima VM
Biochim Biophys Acta; 2014 Mar; 1840(3):945-50. PubMed ID: 24513454
[TBL] [Abstract][Full Text] [Related]
26. In vitro antibacterial and hemolytic activities of crotamine, a small basic myotoxin from rattlesnake Crotalus durissus.
Oguiura N; Boni-Mitake M; Affonso R; Zhang G
J Antibiot (Tokyo); 2011 Apr; 64(4):327-31. PubMed ID: 21386851
[TBL] [Abstract][Full Text] [Related]
27. Crotamine is a novel cell-penetrating protein from the venom of rattlesnake Crotalus durissus terrificus.
Kerkis A; Kerkis I; Rádis-Baptista G; Oliveira EB; Vianna-Morgante AM; Pereira LV; Yamane T
FASEB J; 2004 Sep; 18(12):1407-9. PubMed ID: 15231729
[TBL] [Abstract][Full Text] [Related]
28. Biophysical and biological properties of small linear peptides derived from crotamine, a cationic antimicrobial/antitumoral toxin with cell penetrating and cargo delivery abilities.
Dal Mas C; Pinheiro DA; Campeiro JD; Mattei B; Oliveira V; Oliveira EB; Miranda A; Perez KR; Hayashi MAF
Biochim Biophys Acta Biomembr; 2017 Dec; 1859(12):2340-2349. PubMed ID: 28888370
[TBL] [Abstract][Full Text] [Related]
29. Structural and functional analysis of BmjMIP, a phospholipase A2 myotoxin inhibitor protein from Bothrops moojeni snake plasma.
Soares AM; Marcussi S; Stábeli RG; França SC; Giglio JR; Ward RJ; Arantes EC
Biochem Biophys Res Commun; 2003 Mar; 302(2):193-200. PubMed ID: 12604331
[TBL] [Abstract][Full Text] [Related]
30. Structure-function relationship of new crotamine isoform from the Crotalus durissus cascavella.
Toyama OD; Boschero CA; Martins AM; Fonteles CM; Monteiro SH; Toyama HM
Protein J; 2005 Jan; 24(1):9-19. PubMed ID: 15756813
[TBL] [Abstract][Full Text] [Related]
31. DNA-interactive properties of crotamine, a cell-penetrating polypeptide and a potential drug carrier.
Chen PC; Hayashi MA; Oliveira EB; Karpel RL
PLoS One; 2012; 7(11):e48913. PubMed ID: 23145017
[TBL] [Abstract][Full Text] [Related]
32. Identification of crotamine in the venom of Crotalus durissus collilineatus by three different methods.
de Oliveira SA; Magalhães MR; Salazar VC; Valadares MC; da Cunha LC
Toxicon; 2015 Mar; 95():46-51. PubMed ID: 25553594
[TBL] [Abstract][Full Text] [Related]
33. Selective reciprocity in antimicrobial activity versus cytotoxicity of hBD-2 and crotamine.
Yount NY; Kupferwasser D; Spisni A; Dutz SM; Ramjan ZH; Sharma S; Waring AJ; Yeaman MR
Proc Natl Acad Sci U S A; 2009 Sep; 106(35):14972-7. PubMed ID: 19706485
[TBL] [Abstract][Full Text] [Related]
34. Geographic and ontogenic variability in the venom of the neotropical rattlesnake Crotalus durissus: pathophysiological and therapeutic implications.
Saravia P; Rojas E; Arce V; Guevara C; López JC; Chaves E; Velásquez R; Rojas G; Gutiérrez JM
Rev Biol Trop; 2002 Mar; 50(1):337-46. PubMed ID: 12298262
[TBL] [Abstract][Full Text] [Related]
35. The analgesic activity of crotamine, a neurotoxin from Crotalus durissus terrificus (South American rattlesnake) venom: a biochemical and pharmacological study.
Mancin AC; Soares AM; Andrião-Escarso SH; Faça VM; Greene LJ; Zuccolotto S; Pelá IR; Giglio JR
Toxicon; 1998 Dec; 36(12):1927-37. PubMed ID: 9839677
[TBL] [Abstract][Full Text] [Related]
36. Biological activities of a new crotamine-like peptide from Crotalus oreganus helleri on C2C12 and CHO cell lines, and ultrastructural changes on motor endplate and striated muscle.
Salazar E; Rodriguez-Acosta A; Lucena S; Gonzalez R; McLarty MC; Sanchez O; Suntravat M; Garcia E; Finol HJ; Giron ME; Fernandez I; Deba F; Bessac BF; Sánchez EE
Toxicon; 2020 Dec; 188():95-107. PubMed ID: 33065200
[TBL] [Abstract][Full Text] [Related]
37. Unraveling the antifungal activity of a South American rattlesnake toxin crotamine.
Yamane ES; Bizerra FC; Oliveira EB; Moreira JT; Rajabi M; Nunes GL; de Souza AO; da Silva ID; Yamane T; Karpel RL; Silva PI; Hayashi MA
Biochimie; 2013 Feb; 95(2):231-40. PubMed ID: 23022146
[TBL] [Abstract][Full Text] [Related]
38. Amino acid sequences of myotoxins from Crotalus viridis concolor venom.
Bieber AL; McParland RH; Becker RR
Toxicon; 1987; 25(6):677-80. PubMed ID: 3629618
[TBL] [Abstract][Full Text] [Related]
39. A new small myotoxin from the venom of the prairie rattlesnake (Crotalus viridis viridis).
Griffin PR; Aird SD
FEBS Lett; 1990 Nov; 274(1-2):43-7. PubMed ID: 2253781
[TBL] [Abstract][Full Text] [Related]
40. Individual venom profiling of Crotalus durissus terrificus specimens from a geographically limited region: crotamine assessment and captivity evaluation on the biological activities.
Lourenço A; Zorzella Creste CF; de Barros LC; Delazari dos Santos L; Pimenta DC; Barraviera B; Ferreira RS
Toxicon; 2013 Jul; 69():75-81. PubMed ID: 23380403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
